One of IDF Europe's main activities is policy and advocacy at the regional and national level.
At regional level, the main targets of IDF Europe are the EU Institutions (European Parliament and European Commission), the Council of Europe and the World Health Organization European Region.
At national level, the Federation acts as a bridge for its Members by informing them on the latest policy developments Europe-wide. This way, national members can perfom their policy and advocay activities at national level, using regional activities as a reference.
Since 2012, IDF Europe awards two IDF Europe Prizes in Diabetes yearly to reward excellence, innovation, and commitment in diabetes: the IDF Europe Young Researcher Award, and the IDF Europe Long-Standing Achievement Award.
These Awards aim at increasing awareness about diabetes and acknowledging outstanding individuals who are dedicated to improving the lives of people with diabetes.
Gavin Griffiths wins the 2019 IDF Europe Long-Standing Achievement Prize
Founder of DIAthlete, Gavin was diagnosed with Type 1 diabetes (T1D) in 2000 at the age of 8. After initially struggling to deal with the condition and reconciling it with engaging in sporting activities, Gavin is now an endurance runner, who has taken over 100 challenges across the world to fundraise and support various causes and charities linked to T1D.
The award was presented on World Diabetes Day by Marjatta Stenius-Kaukonen, former MEP for Finland, IDF Europe Chair, Prof Dr Sehnaz Karadeniz, and Mr Maurizio Guidi during the IDF Europe Symposium at the European Parliament.
Commenting on the award, Kyle Jacques Rose, an IDF Europe Board Member, stated: “Gavin has shown great persistence from an early age. His work via DiAthlete (and the League of DIAthelete Heroes) helps strengthen our global community and inspires many whether it be warming up on a football pitch, running multiple marathons, or carrying on events at local support groups/hospitals. We believe in what he has built and thank him for his commitment to our cause over the years."
Maurizio Guidi, Lilly Diabetes Corporate Affairs, External Engagement Leader, added “Diabetes is a lifelong challenge. That’s why the needs of people with diabetes have continually been an inspiration for Lilly, since 1923, when we pioneered the production of the first insulin treatment. But we know that even with the best of medicines, managing diabetes and reaching individual treatment goals can be hard – understanding and taking the medicine shouldn’t be. We are proud of our long-lasting collaboration with IDF Europe and very honoured that IDF E and Lilly long standing achievement award goes this year to Gavin for his remarkable contribution.”
In his address which concluded the IDF Europe Symposium, Gavin shared a very positive message on living with diabetes. “I am honoured and humbled to receive this IDF Europe Long-standing Achievement award. I have shared a journey of many highs & lows – often quite literally, as far as living with type 1 diabetes is concerned – and every experience has been one to reflect and learn from; diabetes doesn’t have to close your doors in life, but open up a new part of you to grow into in your own time. What we need, as far as education, communication and medical access are concerned, is to connect a platform for us all to grow together.”
The IDF Europe Long Standing Achievement Prize is supported by Lilly and Company
IDF Europe Prizes 2018
IDF Europe is thrilled to announce that the 2018 IDF Europe Prizes in Diabetes winners!
This Prize is awarded to a young researcher, under the age of 40, who is involved in innovative patient-oriented research in diabetes and/or its complications. Their work should demonstrate commitment to diabetes research leading to improved health outcomes for people with diabetes.
In recent years, we have seen the emergence of a new type of communication around health issues where people directly affected by a disease become the focal point for the flow information. Social media, including personal blogs and exchange platforms such as Facebook, Twitter, etc. now play a major role in communicating health messages which, when conveying accurate information, can be a great source of inspiration and support. For people with diabetes this usually translates into the provision of peer information mostly regarding daily self-management, patient empowerment and rights. The feelings of empathy, proximity and of being understood created by these channels are essential and demonstrate the success of such online platforms.
It takes time, dedication and talent to provide accurate, frequently updated and interesting information in a format which is of interest to the readers. IDF Europe would like to recognise this commitment by way of a Social Media Prize in Diabetes.
The award for social media is supported by a sponsorship from Eli Lilly and Company.